People · Operator
Named in public records as an officer, director or promoter · active 2009–2024 · Pharmaceuticals, Retailing, Pharma, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| TORL Biotherapeutics LLC | — | Pharmaceuticals | Series D+ | $158.3M | $1.8B | 2024 |
| Quidsi Inc | — | Retailing | Series B | $30.0M | $169.2M | 2009 |
| 1200 Pharma LLC | — | Pharma | Series A | $14.1M | $13.2M | 2017 |
| Sienza, Inc. | — | Other | Seed | $1.8M | $32.5M | 2017 |
David Licata at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David Licata on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Mark Attanasio | 2 | 3 |
| Dennis Slamon | 2 | 2 |
| SAMEER GANDHI | 1 | 17 |
| Tony Florence | 1 | 15 |
| Jeremy Levine | 1 | 12 |
| David Chang | 1 | 6 |
| Leonard Lodish | 1 | 4 |
| Marc Lore | 1 | 4 |
| Neil ` O'Brien | 1 | 3 |
| Mark Alles | 1 | 3 |
| Mory Gharib | 1 | 3 |
| LEE SAILOR | 1 | 2 |
| Christina Carbonell | 1 | 2 |
| Amit Sinha | 1 | 2 |
| Matthew Tasooji | 1 | 2 |
| William Meurer | 1 | 2 |
| Eugene Hertz | 1 | 1 |
| Brian Stoltz | 1 | 1 |
| Lynn Seely | 1 | 1 |
| Rob Sobhani | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.